Skip to main content
logo
Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.6137
-0.0110 (-1.76%)
Jul 28, 2026, 4:00 PM EDT - Market closed

Aprea Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
8718181863
Market Cap Growth
-27.31%-61.25%2.68%0.11%-72.04%-39.81%
Enterprise Value
-39.04-6.88-3.51-2.73-9.939.85
Last Close Price
0.610.853.294.706.6257.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
60.2624.4612.0030.11--
PB Ratio
0.180.560.931.040.681.27
P/TBV Ratio
0.130.450.941.000.431.23

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--24.09-2.33-4.69--
EV/EBITDA Ratio
-0.520.250.180.09-
EV/EBIT Ratio
-0.520.240.180.09-
EV/FCF Ratio
-0.530.260.220.40-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.12-1.17-1.18-1.27-1.12-1.07
Net Debt / EBITDA Ratio
3.701.111.601.400.251.42
Net Debt / FCF Ratio
3.871.131.681.761.151.40
Asset Turnover
0.000.010.060.0200
Quick Ratio
8.775.286.804.938.997.25
Current Ratio
8.925.637.015.149.427.73
Return on Equity (ROE)
-43.09%-74.58%-66.65%-63.19%-294.69%-58.51%
Return on Assets (ROA)
-39.59%-66.31%-61.42%-58.60%-260.73%-50.05%
Return on Invested Capital (ROIC)
-3403.77%-3412.94%-5378.95%-23549.40%-52515.20%-6971.00%
Return on Capital Employed (ROCE)
-45.34%-78.34%-73.65%-68.43%-296.60%-58.98%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-46.20%-18.67%-52.31%-118.32%-55.69%-0.72%
Total Shareholder Return
-46.20%-18.67%-52.31%-118.32%-55.69%-0.72%
SEC Filings: 10-K · 10-Q